Jun Ma - Concepedia

Author

Jun Ma

Sun Yat-sen University ORCID

Also Known As

Brigette Ma, Chua, M L K, Hongbo Zhang, J Ma, J. Ma, JUN MA, Jiahuai Ma, Jiaying Ma, Jia‐yuan Ma, Jinfeng Li

Publications

43.2K

Citations

101

H-Index

308

Concepts

All Affiliations

Sun Yat-sen University Sun Yat-sen University Cancer Center State Key Laboratory of Oncology in South China China Medical University

About

Jun Ma is an author at Sun Yat-sen University specializing in medicine, radiation oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	60	178	14.2K
2	Health Sciences	38	66	7.4K
3	Engineering	18	22	1.4K
4	Natural Sciences	7	7	355
5	Public Health	5	5	126

Jun Ma

528

Publications

35K

Citations

H-Index

Page 1

	Year	Citations
Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial Ying Sun, Wen-Fei Li, Nian-Yong Chen, The Lancet Oncology Radiation TherapyMedicineAdvanced Nasopharyngeal CarcinomaNasopharyngeal CancerInduction Chemotherapy	2016	929
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma Yuan Zhang, Lei Chen, Guoqing Hu, New England Journal of Medicine	2019	889
A Metagenomic Approach to Characterization of the Vaginal Microbiome Signature in Pregnancy Kjersti M. Aagaard, Kevin Riehle, Jun Ma, PLoS ONE DysbiosisMetagenomic ApproachGeneticsVaginal Microbiome SignatureGenomics	2012	688
How Does Intensity-Modulated Radiotherapy Versus Conventional Two-Dimensional Radiotherapy Influence the Treatment Results in Nasopharyngeal Carcinoma Patients? Shu-zhen Lai, Wen‐Fei Li, Lei Chen, International Journal of Radiation OncologyBiologyPhysics Adaptive RadiotherapyRadiation TherapyMedicineRadionuclide TherapyTreatment Results	2010	611
Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial Lei Chen, Chaosu Hu, Xiao-Zhong Chen, The Lancet Oncology Concurrent ChemoradiotherapyRadiation TherapyMedicineAdvanced Nasopharyngeal CarcinomaCancer Management	2011	556
Nuclear m6A reader YTHDC1 regulates alternative polyadenylation and splicing during mouse oocyte development Seth D. Kasowitz, Jun Ma, Stephen J. Anderson, PLoS Genetics OocyteGeneticsMolecular GeneticsReproductive BiologyEpigenetics	2018	554
Single-cell transcriptomics reveals regulators underlying immune cell diversity and immune subtypes associated with prognosis in nasopharyngeal carcinoma Yu‐Pei Chen, Jianhua Yin, Wen‐Fei Li, Cell Research	2020	448
Long Noncoding RNA FAM225A Promotes Nasopharyngeal Carcinoma Tumorigenesis and Metastasis by Acting as ceRNA to Sponge miR-590-3p/miR-1275 and Upregulate ITGB3 Zi‐Qi Zheng, Zhi‐Xuan Li, Guan‐Qun Zhou, Cancer Research	2019	415
The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma Ling‐Long Tang, Yu‐Pei Chen, Chuanben Chen, Cancer Communications	2021	374
Results of a Prospective Randomized Trial Comparing Neoadjuvant Chemotherapy Plus Radiotherapy With Radiotherapy Alone in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma Jun Ma, Hai‐Qiang Mai, Ming‐Huang Hong, Journal of Clinical Oncology	2001	364

Page 1